losartan has been researched along with u 73122 in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asada, Y; Hirose, K; Iino, M; Takasaka, T; Yamazawa, T | 1 |
| Carroll, MA; Croft, KD; McGiff, JC; Sanchez-Mendoza, A | 1 |
| Elia, MG; Greco, S; Marsigliante, S; Muscella, A; Salvatore, P; Storelli, C | 1 |
| Han, HJ; Heo, JS; Lee, YJ | 1 |
| Akçit, F; Cağlar, S; Cetin, A; Ozturk, OH; Tokay, A; Yeşilkaya, A | 1 |
| Aranguiz, P; Chiong, M; Copaja, M; Díaz-Araya, G; Garcia, L; Lavandero, S; Letelier, A; Mateluna, F; Muñoz, JP; Soto, C; Thomas, WG; Vivar, R | 1 |
| Brailoiu, E; Brailoiu, GC; Deliu, E; Motoc, D; Tica, AA | 1 |
| Anand-Srivastava, MB; Li, Y | 1 |
| Barro-Soria, R; Castrop, H; Foeckler, R; Müller, C; Stindl, J; Strauß, O; Todorov, V | 1 |
| Adebiyi, A; Soni, H | 1 |
| Bosco, D; Cassel, R; Chauvin, MA; Chikh, K; Dubois, S; Ducreux, S; Madec, AM; Mesnier, A; Rieusset, J; Thivolet, C; Van Coppenolle, F; Vial, G | 1 |
11 other study(ies) available for losartan and u 73122
| Article | Year |
|---|---|
Dynamic Ca2+ signalling in rat arterial smooth muscle cells under the control of local renin-angiotensin system.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Aniline Compounds; Animals; Antihypertensive Agents; Arteries; Calcium; Calcium Signaling; Calcium-Transporting ATPases; Captopril; Enzyme Inhibitors; Estrenes; Evoked Potentials; Fluorescent Dyes; Indoles; Losartan; Male; Muscle, Smooth, Vascular; Periodicity; Phosphodiesterase Inhibitors; Pyrrolidinones; Rats; Rats, Wistar; Renin-Angiotensin System; Sarcoplasmic Reticulum; Stimulation, Chemical; Tail; Type C Phospholipases; Vasoconstriction; Xanthenes | 1999 |
Angiotensin II releases 20-HETE from rat renal microvessels.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Arachidonic Acids; Arterioles; Capillaries; Cytochrome P-450 Enzyme System; Estrenes; Gas Chromatography-Mass Spectrometry; Hydroxyeicosatetraenoic Acids; Imidazoles; Kidney; Losartan; Male; NADP; Phosphodiesterase Inhibitors; Pyridines; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Type C Phospholipases | 2000 |
Activation of angiotensin II type I receptor promotes protein kinase C translocation and cell proliferation in human cultured breast epithelial cells.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Biological Transport; Breast; Calcium Signaling; Carbazoles; Cell Division; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Estrenes; Female; Humans; Indoles; Isoenzymes; Losartan; Protein Kinase C; Pyrrolidinones; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Staurosporine; Thapsigargin; Type C Phospholipases | 2002 |
ANG II increases 2-deoxyglucose uptake in mouse embryonic stem cells.
Topics: Alkaline Phosphatase; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biological Transport; Calcimycin; Calcium; Cell Line; Cell Proliferation; Deoxyglucose; DNA-Binding Proteins; Dose-Response Relationship, Drug; Embryo, Mammalian; Estrenes; Gene Expression; Glucose Transporter Type 1; Imidazoles; Inositol Phosphates; Losartan; Membrane Transport Proteins; Mice; Monosaccharide Transport Proteins; Neomycin; Octamer Transcription Factor-3; Phosphodiesterase Inhibitors; Protein Kinase C; Pyridines; Pyrrolidinones; Stem Cells; Transcription Factors; Type C Phospholipases; Vasoconstrictor Agents | 2005 |
Angiotensin II-induced MAPK phosphorylation mediated by Ras and/or phospholipase C-dependent phosphorylations but not by protein kinase C phosphorylation in cultured rat vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Blotting, Western; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estrenes; Farnesol; Indoles; Losartan; Male; Maleimides; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Phosphorylation; Protein Kinase C; Pyrrolidinones; ras Proteins; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Salicylates; Time Factors; Type C Phospholipases | 2007 |
Phospholipase C/protein kinase C pathway mediates angiotensin II-dependent apoptosis in neonatal rat cardiac fibroblasts expressing AT1 receptor.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Apoptosis; Carbazoles; Cells, Cultured; Estrenes; Fibroblasts; Gene Expression; Losartan; Protein Kinase C; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction; Type C Phospholipases | 2008 |
Intracellular angiotensin II activates rat myometrium.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Arsenicals; Autophagy; Brefeldin A; Calcium Signaling; Carbolines; Cells, Cultured; Egtazic Acid; Endocytosis; Endoplasmic Reticulum; Endosomes; Enzyme Inhibitors; Estrenes; Female; Heparin; Imidazoles; Inositol 1,4,5-Trisphosphate Receptors; Losartan; Lysosomes; Macrocyclic Compounds; Macrolides; Models, Biological; Myometrium; NADP; Oxazoles; Piperazines; Pyridines; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Ryanodine; Saralasin; Signal Transduction; Sirolimus; Type C Phospholipases; Uterus | 2011 |
Implication of multiple signaling pathways in the regulation of angiotensin II induced enhanced expression of Giα proteins in vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Bucladesine; Calcium; Cell Line; Chelating Agents; Dactinomycin; Drug Interactions; Egtazic Acid; Estrenes; Gallic Acid; Gene Expression Regulation; Genistein; GTP-Binding Protein alpha Subunits, Gi-Go; Imidazoles; Losartan; Nucleic Acid Synthesis Inhibitors; Protein Kinase Inhibitors; Pyridines; Pyrrolidinones; Rats; Signal Transduction; Type C Phospholipases | 2012 |
Angiotensin-2-mediated Ca2+ signaling in the retinal pigment epithelium: role of angiotensin-receptor-associated-protein and TRPV2 channel.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Calcium; Estrenes; Imidazoles; Immunohistochemistry; Losartan; Macrocyclic Compounds; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oxazoles; Pyrrolidinones; Retinal Pigment Epithelium; RNA, Small Interfering; Signal Transduction; Swine; TRPV Cation Channels | 2012 |
Pressor and renal regional hemodynamic effects of urotensin II in neonatal pigs.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Arterial Pressure; Boron Compounds; Dose-Response Relationship, Drug; Estrenes; Hemodynamics; Inositol 1,4,5-Trisphosphate Receptors; Kidney; Losartan; Peptide Fragments; Pyrrolidinones; Renal Circulation; Swine; Type C Phospholipases; Urotensins; Vascular Resistance | 2013 |
Losartan, an angiotensin II type 1 receptor blocker, protects human islets from glucotoxicity through the phospholipase C pathway.
Topics: Angiotensin II Type 1 Receptor Blockers; Calcium; Calcium Signaling; Cells, Cultured; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Estrenes; Glucose; Humans; Inositol 1,4,5-Trisphosphate Receptors; Insulin; Insulin-Secreting Cells; Losartan; Phospholipase C beta; Phospholipase C gamma; Pyrrolidinones; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2013 |